Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Journal of the National Cancer Institute
|
August 1, 2013
Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression
Shom Goel, Nisha Gupta, Brian P Walcott, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2015
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
Sara M Tolaney, Yves Boucher, Dan G Duda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2026
Single-cell transcriptomics reveals immune landscape dynamics in metastatic hormone receptor-positive breast cancer treated with abemaciclib and endocrine therapy
Corinne H Strawser, Binita Chakraborty, Daniel Michaud, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 17, 2012
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
David P Kodack, Euiheon Chung, Hiroshi Yamashita, et al.
Nature
|
August 17, 2017
CDK4/6 inhibition triggers anti-tumour immunity
Shom Goel, Molly J DeCristo, April C Watt, et al.
Cancer Discovery
|
May 4, 2021
Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation
Max Heckler, Lestat R Ali, Eleanor Clancy-Thompson, et al.
Elife
|
July 31, 2018
An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer
Ji Li, Peter S Choi, Christine L Chaffer, et al.
Cancer Cell
|
April 12, 2017
Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers
Per Hydbring, Yinan Wang, Anne Fassl, et al.
Cancer Cell
|
November 12, 2024
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion
Rei Kudo, Anton Safonov, Catherine Jones, et al.
Nature Medicine
|
June 9, 2016
Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases
Jing Ni, Shakti H Ramkissoon, Shaozhen Xie, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Journal of the National Cancer Institute
|
August 1, 2013
Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression
Shom Goel, Nisha Gupta, Brian P Walcott, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2015
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
Sara M Tolaney, Yves Boucher, Dan G Duda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2026
Single-cell transcriptomics reveals immune landscape dynamics in metastatic hormone receptor-positive breast cancer treated with abemaciclib and endocrine therapy
Corinne H Strawser, Binita Chakraborty, Daniel Michaud, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 17, 2012
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
David P Kodack, Euiheon Chung, Hiroshi Yamashita, et al.
Nature
|
August 17, 2017
CDK4/6 inhibition triggers anti-tumour immunity
Shom Goel, Molly J DeCristo, April C Watt, et al.
Cancer Discovery
|
May 4, 2021
Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation
Max Heckler, Lestat R Ali, Eleanor Clancy-Thompson, et al.
Elife
|
July 31, 2018
An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer
Ji Li, Peter S Choi, Christine L Chaffer, et al.
Cancer Cell
|
April 12, 2017
Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers
Per Hydbring, Yinan Wang, Anne Fassl, et al.
Cancer Cell
|
November 12, 2024
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion
Rei Kudo, Anton Safonov, Catherine Jones, et al.
Nature Medicine
|
June 9, 2016
Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases
Jing Ni, Shakti H Ramkissoon, Shaozhen Xie, et al.
Page
of 7